Intervention Protocol

Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegaly.

  1. Eric V Balti*,
  2. Elvis A Akwo,
  3. Leopold Fezeu,
  4. Andre Pascal Kengne,
  5. Eugene Sobngwi,
  6. Jean Claude Mbanya

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 20 JAN 2010

DOI: 10.1002/14651858.CD008292


How to Cite

Balti EV, Akwo EA, Fezeu L, Kengne AP, Sobngwi E, Mbanya JC. Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegaly. (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008292. DOI: 10.1002/14651858.CD008292.

Author Information

  1. University of Yaounde I, National Obesity Centre and HoPiT Research Group, FMSB, Yaounde, South Region, Cameroon

  1. The George Institute for International Health, University of Sydney

  2. Institute of Health and Society, Newcastle University

*Eric V Balti, National Obesity Centre and HoPiT Research Group, FMSB, University of Yaounde I, PO Box 7535, Yaounde, South Region, Cameroon. baltieric@yahoo.fr. baltivounsia@yahoo.fr.

Publication History

  1. Publication Status: New
  2. Published Online: 20 JAN 2010

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegaly.